Similar articles

• Predicting and preventing the emergence of antiviral drug resistance in HSV-2.

  Blower SM, Porco TC, Darby G. Blower SM, et al. Nat Med. 1998 Jun;4(6):673-8. doi: 10.1038/nm0698-673. Nat Med. 1998. PMID: 9623975
• Genital ulcer disease treatment policies and herpes.

  O'Farrell N, Moodley P. O'Farrell N, et al. Sex Transm Dis. 2011 Feb;38(2):150. doi: 10.1097/OLQ.0b013e318205432b. Sex Transm Dis. 2011. PMID: 21209599 No abstract available.
• [Treatment of genital herpes].

  Hiltunen-Back E. Hiltunen-Back E. Duodecim. 2001;117(11):1175-9; quiz 1180, 1205. Duodecim. 2001. PMID: 12116718 Finnish. No abstract available.
• An update on short-course episodic and prevention therapies for herpes genitalis.

  Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L. Corey L, et al. Herpes. 2007 Jun;14 Suppl 1:5A-11A. Herpes. 2007. PMID: 17877886 Review.
• [Genital herpes].

  Tewald F, Enders M, Regnath T, Hassler D. Tewald F, et al. Dtsch Med Wochenschr. 2006 Nov 24;131(47):2641-2. Dtsch Med Wochenschr. 2006. PMID: 17190019 Review. German. No abstract available.